Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. IGC Pharma Inc. (IGC) Message Board

420 with CNW — Germany to Proceed with Toned-Dow

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 436
(Total Views: 161)
Posted On: 04/11/2023 4:43:51 PM
Avatar
Posted By: NetworkNewsWire
420 with CNW — Germany to Proceed with Toned-Down Marijuana Legalization Plan as EU Review Awaits

Officials in Germany intend to move forward with a toned-down version of cannabis legalization after abandoning — at least temporarily — a more comprehensive proposal that would have brought about legal cannabis sales throughout the nation. Karl Lauterbach, the nation’s health minister, had promised to introduce new marijuana regulations by the end of March this year.

The new model, which consists of two parts, was first reported by Zeit and aims to legalize cannabis countrywide without breaking EU regulations. The model will, for four years, permit restricted cannabis sales in some areas, much like a pilot program. In doing so, officials would be able to observe how reforms were being implemented in both urban centers and more rural areas. The program can then be expanded to other regions of the nation if it is deemed successful.

Lauterbach’s plan would also permit Germans to cultivate marijuana for personal use. While the latter part of the plan would require review by the EU Commission, the former would not, according to reports.

Although specifics of the homegrow rules have not been decided, reports indicate that the proposal would permit consumers to own up to 30 marijuana plants. Additionally, independent cultivators can distribute the produce among themselves via “marijuana clubs.” These clubs are already legal in Spain and the Netherlands.

Last year, government representatives from the Netherlands, Germany, Luxembourg and Malta met to talk about legalizing marijuana. Moreover, the country’s federal cabinet approved a preliminary outline for a legalization bill at the end of last year, but the government wanted European Union approval to make sure that enacting the legislation wouldn’t violate international obligations.

Under that preliminary framework, persons older than 18 years of age would have legal access to possess up to 30 grams of cannabis, which could be bought from establishments with federal licenses. Eligible persons could also cultivate up to three marijuana plants for their own use, subject to restrictions on enclosure to keep minors out.

The plan calls for a special consumption tax in addition to the nation’s sales tax being applied to marijuana. And after the reform is put into effect, all ongoing criminal cases involving offenses that are now legal will be halted.

Earlier this month, Lauterbach stated that officials would be revising the proposal before introducing a bill in parliament as they had received “positive feedback” from the EU The framework was the result of several months of analysis and discussion between the German government and the nation’s coalition government. A series of hearings intended to inform legislation to end the nation’s prohibition were launched last summer by officials as a steppingstone toward legalization.

As more countries around the world take steps to end the prohibition of marijuana, many companies such as IGC Pharma Inc. (NYSE American: IGC) are going a step further to develop medicines from compounds extracted from this plant, and these compounds are expected to gain the approval of regulators once the the clinical development process has been successfully completed.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer



(0)
(0)




IGC Pharma Inc. (IGC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us